Postbronchodilator lung function improvements with benralizumab for patients with severe asthma

Sameer K. Mathur; Brian D. Modena; Hanneke Coumou; Peter Barker; James L. Kreindler; James G. Zangrilli

doi:https://doi.org/10.1111/all.14178

Postbronchodilator lung function improvements with benralizumab for patients with severe asthma

Sameer K. Mathur, Brian D. Modena, Hanneke Coumou, Peter Barker, James L. Kreindler, James G. Zangrilli

Doctoral School

Research output: Contribution to journal › Letter › Academic › peer-review

11 Citations (Scopus)

Original language	English
Pages (from-to)	1507-1510
Number of pages	4
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	75
Issue number	6
DOIs	https://doi.org/10.1111/all.14178
Publication status	Published - 1 Jun 2020

Access to Document

https://doi.org/10.1111/all.14178

Cite this

@article{1f776cef05da42c2807d5ca11a88aca7,

title = "Postbronchodilator lung function improvements with benralizumab for patients with severe asthma",

author = "Mathur, {Sameer K.} and Modena, {Brian D.} and Hanneke Coumou and Peter Barker and Kreindler, {James L.} and Zangrilli, {James G.}",

note = "Funding Information: Funding for this study was provided by AstraZeneca. Writing and editing support, including preparation of the draft manuscript under the direction and guidance of the authors, incorporating author feedback, and manuscript submission, was provided by Alan Saltzman, PhD, of JK Associates, Inc (Conshohocken, PA, USA), and Michael A. Nissen, ELS, of AstraZeneca (Gaithersburg, MD, USA). Writing support was funded by AstraZeneca. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = jun,

day = "1",

doi = "https://doi.org/10.1111/all.14178",

language = "English",

volume = "75",

pages = "1507--1510",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Postbronchodilator lung function improvements with benralizumab for patients with severe asthma

AU - Mathur, Sameer K.

AU - Modena, Brian D.

AU - Coumou, Hanneke

AU - Barker, Peter

AU - Kreindler, James L.

AU - Zangrilli, James G.

N1 - Funding Information: Funding for this study was provided by AstraZeneca. Writing and editing support, including preparation of the draft manuscript under the direction and guidance of the authors, incorporating author feedback, and manuscript submission, was provided by Alan Saltzman, PhD, of JK Associates, Inc (Conshohocken, PA, USA), and Michael A. Nissen, ELS, of AstraZeneca (Gaithersburg, MD, USA). Writing support was funded by AstraZeneca. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/6/1

Y1 - 2020/6/1

UR - http://www.scopus.com/inward/record.url?scp=85079073345&partnerID=8YFLogxK

U2 - https://doi.org/10.1111/all.14178

DO - https://doi.org/10.1111/all.14178

M3 - Letter

C2 - 31925789

SN - 0105-4538

VL - 75

SP - 1507

EP - 1510

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 6

ER -

Postbronchodilator lung function improvements with benralizumab for patients with severe asthma

Access to Document

Other files and links

Cite this